Compound class:
Synthetic organic
Comment: The discovery of the TL-77, is described in [2] (and also as compound 9a in [1]). This compound is reported to have improved oral bioavailability compared to rigosertib, and represents a lead anti-mitotic, anti-cancer agent with potential for further development.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-(2-methoxy-5-{[(E)-2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}pyridin-3-yl)methanesulfonamide |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL3261266 |
GtoPdb PubChem SID | 223366165 |
PubChem CID | 54759259 |
Search Google for chemical match using the InChIKey | HEBBDGMHRHUJRY-VOTSOKGWSA-N |
Search Google for chemicals with the same backbone | HEBBDGMHRHUJRY |
UniChem Compound Search for chemical match using the InChIKey | HEBBDGMHRHUJRY-VOTSOKGWSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HEBBDGMHRHUJRY-VOTSOKGWSA-N |